Skip to content

High-Intensity Interval Training vs Moderate-Intensity Continuous Training in Phase II Cardiac Rehabilitation

Effects of High-Intensity Interval Training vs Moderate-Intensity Continuous Training on Ejection Fraction, Functional Capacity, and Lipid Profiles in Phase II Cardiac Rehabilitation

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07619664
Enrollment
66
Registered
2026-06-02
Start date
2026-06-01
Completion date
2026-08-01
Last updated
2026-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease

Keywords

Cardiac Rehabilitation ,High-Intensity Interval Training

Brief summary

This randomized controlled trial aims to compare the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) in patients undergoing Phase II cardiac rehabilitation after coronary artery disease or post-angioplasty. A total of 66 participants will be randomly allocated into two groups: HIIT (n=33) and MICT (n=33). The intervention will be conducted 3 times per week using treadmill-based exercise protocols under heart rate monitoring. Primary outcomes include changes in left ventricular ejection fraction, functional capacity measured by 6-minute walk test, and lipid profile parameters before and after intervention. Secondary assessment includes health-related quality of life (HRQoL). The study aims to determine which exercise modality provides superior cardiovascular and functional improvement in stable cardiac patients during supervised rehabilitation.

Detailed description

This randomized controlled trial will compare the effects of High-Intensity Interval Training (HIIT) and Moderate-Intensity Continuous Training (MICT) in patients undergoing Phase II cardiac rehabilitation after stable coronary artery disease or post-angioplasty. A total of 66 participants will be randomly assigned into two groups. The HIIT group will perform treadmill-based interval exercise 3 times per week at 85-95% heart rate reserve with active recovery periods, while the MICT group will perform continuous treadmill exercise at 65-75% heart rate reserve for 30-45 minutes. Primary outcomes include left ventricular ejection fraction (echocardiography), functional capacity (6-minute walk test), and lipid profile (LDL, HDL, triglycerides, total cholesterol) measured before and after intervention. Health-related quality of life (HRQoL) will also be assessed. The study aims to determine which exercise protocol produces greater improvement in cardiac and functional outcomes.

Interventions

BEHAVIORALHigh-Intensity Interval Training

Participants will perform supervised treadmill-based high-intensity interval training 3 times per week. Each session includes 10 minutes warm-up, 4 intervals of 4 minutes at 85-95% heart rate reserve, 4 minutes active recovery at 50-60% heart rate reserve, followed by 5 minutes cool-down.

Participants will perform supervised treadmill-based continuous exercise 3 times per week at 65-75% heart rate reserve for 30-45 minutes, including warm-up and cool-down periods.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

This study is open-label because both participants and care providers are aware of the assigned exercise intervention. Outcome measurements will be recorded using standardized assessment tools including echocardiography, laboratory investigations, and 6-minute walk test.

Intervention model description

Participants will be randomly assigned into two parallel groups: one group will receive High-Intensity Interval Training (HIIT) and the other group will receive Moderate-Intensity Continuous Training (MICT). Both groups will receive supervised treadmill-based exercise interventions during Phase II cardiac rehabilitation, and outcomes will be compared before and after intervention.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults aged 18-60 years. * Diagnosed with stable coronary artery disease confirmed by angiography, stress testing, or echocardiography. * Left ventricular ejection fraction ≥45%. * Functional NYHA Class I or II. * Medically cleared by a cardiologist to participate in exercise (including recent ECG or stress test if necessary). * Lightly active lifestyle prior to study (not involved in structured exercise programs).

Exclusion criteria

* Unstable angina or recent myocardial infarction (within the past 6 weeks). * Uncontrolled hypertension (systolic BP \>180 mmHg or diastolic BP \>110 mmHg). * Severe valvular heart disease, arrhythmias, or left ventricular dysfunction (EF \<35%). * Musculoskeletal disorders (e.g., severe osteoarthritis, recent fractures, or surgeries) preventing safe participation in exercise. * Neurological disorders affecting mobility or safe exercise (e.g., stroke, Parkinson's disease). * Uncontrolled diabetes mellitus (HbA1c \>9% or recent hypoglycemia). * Any other condition judged by the investigator to make participation unsafe.

Design outcomes

Primary

MeasureTime frameDescription
Left Ventricular Ejection FractionBaseline and at 12 weeks after interventionAssessment of left ventricular ejection fraction using echocardiography to determine changes in cardiac function after intervention.
Functional CapacityBaseline and at 12 weeks after interventionFunctional capacity will be measured by 6-minute walk test to evaluate distance covered during exercise tolerance assessment

Secondary

MeasureTime frameDescription
Lipid ProfileBaseline and at 12 weeks after interventionLaboratory measurement of total cholesterol, LDL, HDL, and triglycerides to assess metabolic changes after exercise intervention.

Countries

Pakistan

Contacts

CONTACTMuhammad Iqbal Tariq, Phd*
iqbal.tariq@riphah.edu.pk333826752
PRINCIPAL_INVESTIGATORArjumand Bano, MSPT

Riphah International University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 3, 2026